Literature DB >> 1186549

Clinical experience with verapamil.

J Vohra, D Hunt, G Sloman.   

Abstract

Verapamil administered by the intravenous route restored sinus rhythm in 33 out of 40 episodes of supraventricular tachycardia. The drug was also effective in reducing ventricular rate in patients with atrial fibrillation. Intracardiac conduction studies using His bundle electrograms showed prolongation of atrioventricular nodal conduction in eight out of nine cases after 5 mg of verapamil were given. The distal conduction was unaffected. Bradycardia and hypotension occurred in two cases and responded promptly to intravenous administration of atropine. Verapamil is an effective antiarrhythmic agent which is, in general, free from significant side effects.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1186549

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

Review 1.  Clinical use of verapamil.

Authors:  J K Vohra
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

Review 2.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.